Evidence map›Paper›PMID 34579067›Full record

Trial reportNutrients2021

Night Vision and Carotenoids (NVC): A Randomized Placebo Controlled Clinical Trial on Effects of Carotenoid Supplementation on Night Vision in Older Adults.

Stuart Richer, Steven Novil, Taylor Gullett, Avni Dervishi, Sherwin Nassiri, Co Duong, Robert Davis, Pinakin Gunvant Davey

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Stuart RicherCaptain James A Lovell Fed Health Care Facility, North Chicago, IL 60064, USA.
Steven NovilCaptain James A Lovell Fed Health Care Facility, North Chicago, IL 60064, USA.
Taylor GullettChicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.
Avni DervishiChicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.
Sherwin NassiriChicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.
Co DuongChicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.ORCID 0000-0002-9238-1853
Robert DavisDavis Eye Care Associates, Oak Lawn, IL 60453, USA.
Pinakin Gunvant DaveyCollege of Optometry, Western University of Health Sciences, Pomona, CA 91766, USA.ORCID 0000-0002-6683-7052
Rosalind Franklin University of Medicine and Science · USCaptain James A. Lovell Federal Health Care Center · USEye Care Associates · USWestern University of Health Sciences · US

Funding

ZeaVision LLC Chesterfield, MO USA NCT04741763 at (www.clinicaltrials.gov). ZeaVision LLC Chesterfield, MO USA NCT04741763 at (www.clinicaltrials.gov).
6 · The paper itself

Abstract

Twilight and low luminance levels are visually challenging environments for the elderly, especially when driving at night. Carotenoid rich diets are known to increase macular pigment optical density (MPOD), which in turn leads to an improvement in visual function. It is not known whether augmenting MPOD can lead to a decrease in vision related night driving difficulties. Additionally, it is unknown if carotenoid supplementation provides additional measurable benefits to one's useful field of view (UFOV) along with a decreased composite crash risk score. The aim of the study was to evaluate changes in night vision function and UFOV in individuals that took carotenoid vitamin supplements for a six-month period compared to a placebo group.

methodsA prospective, randomized, double-blind, six-month trial of a 14 mg zeaxanthin/7 mg lutein-based supplement was carried out. Participants were randomized into active or placebo group (approx 2:1).

results

conclusionsThe NVC demonstrates that augmenting MPOD in individuals with difficulty in night vision showed measurable benefits in numerous visual functions that are important for night vision driving in this small sample RCT. Additionally, we observed an improvement in UFOV divided attention test scores and decreased composite risk scores.

Indexed as

Dietary SupplementsAccidents, TrafficAgedAutomobile DrivingDouble-Blind MethodFemaleHumansLuteinMacula LuteaMacular DegenerationMacular PigmentMaleMiddle AgedNight VisionProspective StudiesVision, OcularLuteinMacular PigmentZeaxanthinsautomobile crash riskcholecystectomyglare disabilityluminance preferenceluteinmacular pigment optical densitynight visionzeaxanthin

Identifiers

PMID34579067
PMCPMC8471486
OpenAlexW3200323394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.